Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Status:
Recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone
marrow transplants in patients with non-malignant disease who are less than 21 years of age
and could benefit from the procedure.